Literature DB >> 28538512

Necrotizing Ulcer After BCG Vaccination in a Girl With Leukocyte-adhesion Deficiency Type 1.

Hidemitsu Kurosawa1, Tomoyuki Mizukami2,3, Hiroyuki Nunoi2, Masaya Kato1, Yuya Sato1, Mayuko Okuya1, Keitaro Fukushima1, Yoshihiko Katsuyama4, Osamu Arisaka1.   

Abstract

Leukocyte-adhesion deficiency-1 is a recessively inherited disorder associated with recurrent bacterial infections, severe periodontitis, peripheral leukocytosis, and impaired wound healing. We diagnosed moderate-type leukocyte-adhesion deficiency-1 in a 7-year-old girl who developed a necrotizing ulcer after Bacillus Calmette-Guerin vaccination. The patient showed moderate expression of CD18 in neutrophils with a homozygous splice mutation with c.41_c.58+2dup20 of ITGB2 and experienced recurrent severe infections complicated with systemic lupus erythematosus. She received hematopoietic stem cell transplantation from a matched elder brother with heterozygous mutation of ITGB2, and has since remained free of infection and systemic lupus erythematosus symptoms without immunosuppression therapy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28538512     DOI: 10.1097/MPH.0000000000000853

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

1.  Novel ITGB2 Mutation Is Responsible for a Severe Form of Leucocyte Adhesion Deficiency Type 1.

Authors:  Ahmed Bouhouche; Yasmin Tabache; Omar Askander; Hicham Charoute; Nada Mesnaoui; Lamiae Belayachi; Naima El Hafidi; Houyam Hardizi; Elmostafa El Fahime; Naima Erreimi; Abdelhamid Barakat; Mohammed Khattab; Fouad Seghrouchni; Amine El Hassani
Journal:  Biomed Res Int       Date:  2022-03-03       Impact factor: 3.411

2.  Three novel homozygous ITGB2 mutations among two patients with leukocyte adhesion defect type-1: Two case reports.

Authors:  Yiwa Suksawat; Punchama Pacharn; Nunthana Siripipattanamongkol; Boonchai Boonyawat
Journal:  World J Clin Pediatr       Date:  2022-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.